Patient characteristics of the Combination of Anti-Rheumatic Drugs in Early RA (CARDERA) clinical trial and the Early RA Network (ERAN) observational cohort.
| Characteristics | Full Dataset at 2 Yrs | |
|---|---|---|
| Clinical Trial, n = 378 | Observational Cohort, n = 194 | |
| Women, n (%) | 259 (68) | 140 (72) |
| Median disease duration (IQR), mo | 2 (0, 5) | 2 (1, 2) |
| Median age at onset (IQR), yrs | 5 (46, 64) | 55 (47, 64) |
| Rheumatoid factor, n (%) | 259 (68) | 134 (72) |
| Rheumatoid nodules, n (%) | 82 (22) | 54 (28) |
| Median baseline DAS28 (IQR) | 5.78 (4.88, 6.77) | 4.77 (3.75, 5.77) |
| Median baseline HAQ (IQR) | 1.16 (0.12, 2.12) | 1.25 (0.59, 1.75) |
| Median Larsen score (IQR) | 6.5 (2.5, 16.5) | — |
| Erosions at baseline, n (%) | — | 56 (29) |
IQR: interquartile range; DAS28: 28-joint Disease Activity Score; HAQ: Health Assessment Questionnaire.